Effect of flash glucose monitoring on glycemic control, hypoglycemia, diabetes-related distress, and resource utilization in the Association of British Clinical …
…, S Kamaruddin, R Banatwalla, R Herring… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE The FreeStyle Libre (FSL) flash glucose-monitoring device was made available
on the UK National Health Service (NHS) drug tariff in 2017. This study aims to explore the …
on the UK National Health Service (NHS) drug tariff in 2017. This study aims to explore the …
[HTML][HTML] Quality and safety at the point of care: how long should a ward round take?
R Herring, T Desai, G Caldwell - Clinical medicine, 2011 - ncbi.nlm.nih.gov
In April 2009 a ‘considerative checklist’was developed to ensure that all important aspects
of care on a team's routine and post-take general internal medicine ward rounds had been …
of care on a team's routine and post-take general internal medicine ward rounds had been …
[HTML][HTML] SGLT inhibition and euglycaemic diabetic ketoacidosis
…, E Abrol, D Russell-Jones, R Herring - The lancet Diabetes & …, 2015 - thelancet.com
Sodium-glucose co-transporter-2 (SGLT2) inhibitors are now widely used as an adjunctive
treatment in managing type 2 diabetes. 1 Due to their oral administration route, favourable …
treatment in managing type 2 diabetes. 1 Due to their oral administration route, favourable …
The SGLT2 inhibitor dapagliflozin increases the oxidation of ingested fatty acids to ketones in type 2 diabetes
RA Herring, F Shojaee-Moradie, M Stevenage… - Diabetes …, 2022 - Am Diabetes Assoc
OBJECTIVE To investigate the mechanism for increased ketogenesis following treatment
with the SGLT2 inhibitor dapagliflozin in people with type 2 diabetes. RESEARCH DESIGN …
with the SGLT2 inhibitor dapagliflozin in people with type 2 diabetes. RESEARCH DESIGN …
Implementation of a considerative checklist to improve productivity and team working on medical ward rounds
R Herring, G Caldwell, S Jackson - Clinical Governance: An …, 2011 - emerald.com
In the changing environment of the National Health Service (NHS) medical ward rounds have
become increasingly complex. With complexity comes the inevitable risk that things will go …
become increasingly complex. With complexity comes the inevitable risk that things will go …
Predictors of diabetes‐related distress before and after FreeStyle Libre‐1 use: Lessons from the A ssociation of B ritish C linical D iabetologists nationwide study
…, R Banatwalla, R Herring… - Diabetes, Obesity …, 2021 - Wiley Online Library
Aim To identify the baseline demographic and clinical characteristics associated with
diabetes‐related distress (DRD) and factors associated with improvement in DRD after initiating …
diabetes‐related distress (DRD) and factors associated with improvement in DRD after initiating …
Impaired awareness of hypoglycemia and severe hypoglycemia in drivers with diabetes: insights from the Association of British Clinical Diabetologists Nationwide …
…, P Christian, S Saunders, A Lumb, R Herring… - Diabetes …, 2021 - Am Diabetes Assoc
Hypoglycemia is an acute complication in people living with diabetes, with 83% of those with
type 1 diabetes experiencing hypoglycemia at least once a month and even higher rates of …
type 1 diabetes experiencing hypoglycemia at least once a month and even higher rates of …
Metabolic effects of an SGLT2 inhibitor (dapagliflozin) during a period of acute insulin withdrawal and development of ketoacidosis in people with type 1 diabetes
RA Herring, F Shojaee-Moradie, R Garesse… - Diabetes …, 2020 - Am Diabetes Assoc
OBJECTIVE To determine the effect of the sodium–glucose cotransporter 2 inhibitor dapagliflozin
on glucose flux, lipolysis, and ketone body concentrations during insulin withdrawal in …
on glucose flux, lipolysis, and ketone body concentrations during insulin withdrawal in …
Effect of dapagliflozin on cardiac function and metabolic and hormonal responses to exercise
RA Herring, I Parsons… - The Journal of …, 2023 - academic.oup.com
Objective This work aimed to investigate the effect of the SGLT 2 inhibitor, dapagliflozin (DAPA),
on cardiac function and the metabolic and hormonal response to moderate exercise in …
on cardiac function and the metabolic and hormonal response to moderate exercise in …
HDL-apoA-I kinetics in response to 16 wk of exercise training in men with nonalcoholic fatty liver disease
…, M Barrett, NC Jackson, RA Herring… - American Journal …, 2020 - journals.physiology.org
Nonalcoholic fatty liver disease (NAFLD) is characterized by low-circulating concentration of
high-density lipoprotein cholesterol (HDL-C) and raised triacylglycerol (TAG). Exercise …
high-density lipoprotein cholesterol (HDL-C) and raised triacylglycerol (TAG). Exercise …